Kapikian A Z, Wyatt R G, Levine M M, Yolken R H, VanKirk D H, Dolin R, Greenberg H B, Chanock R M
J Infect Dis. 1983 Jan;147(1):95-106. doi: 10.1093/infdis/147.1.95.
Four of 18 volunteers challenged orally with human rotavirus strain D (subgroup 2, serotype Wa) developed a diarrheal illness two to four days after inoculation. Viral shedding was detected in five of the 18 volunteers, whereas 12 (67%) developed serologic evidence of infection. Two volunteers who developed diarrheal illness after the initial inoculation were given the same inoculum 19 months later; neither developed diarrhea, although one developed constitutional and gastrointestinal symptoms. The presence of preinoculation serum immunofluorescent antibody to rotavirus strain D or high levels of neutralizing antibody to Wa or reassortant DS-1 human rotavirus correlated with resistance to diarrheal illness. Although prechallenge serum antibody correlated with resistance to diarrhea and/or shedding of rotavirus, the relationship of preexisting local neutralizing activity in intestinal fluid was less clear-cut.
18名口服人类轮状病毒D株(2亚组,血清型Wa)的志愿者中,有4人在接种后两到四天出现腹泻病。18名志愿者中有5人检测到病毒排泄,而12人(67%)出现感染的血清学证据。两名在初次接种后出现腹泻病的志愿者在19个月后接种相同的接种物;两人均未出现腹泻,尽管其中一人出现全身和胃肠道症状。接种前血清对轮状病毒D株的免疫荧光抗体或对Wa或重配DS-1人轮状病毒的高水平中和抗体的存在与对腹泻病的抵抗力相关。尽管攻击前血清抗体与对腹泻和/或轮状病毒排泄的抵抗力相关,但肠液中预先存在的局部中和活性的关系不太明确。